<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2182-5173</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Medicina Geral e Familiar]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Port Med Geral Fam]]></abbrev-journal-title>
<issn>2182-5173</issn>
<publisher>
<publisher-name><![CDATA[Associação Portuguesa de Medicina Geral e Familiar]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2182-51732021000600507</article-id>
<article-id pub-id-type="doi">10.32385/rpmgf.v37i6.12978</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[CombinAd: avaliação e melhoria da prescrição de contracetivos orais combinados na adolescência]]></article-title>
<article-title xml:lang="en"><![CDATA[CombinAd: assessment and improvement of combined oral contraceptives prescription in adolescence]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[Andreia Silva e]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Neves]]></surname>
<given-names><![CDATA[Gisela Costa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[Afonso Brás]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,ACeS Arrábida USF Sesimbra ]]></institution>
<addr-line><![CDATA[Sesimbra ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,ACeS Arrábida USF Castelo ]]></institution>
<addr-line><![CDATA[Sesimbra ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>30</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>12</month>
<year>2021</year>
</pub-date>
<volume>37</volume>
<numero>6</numero>
<fpage>507</fpage>
<lpage>513</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2182-51732021000600507&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2182-51732021000600507&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2182-51732021000600507&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Objetivos:  Melhorar e adequar a prescrição de contracetivos orais combinados (COC) às adolescentes da Unidade de Saúde Familiar (USF) do Castelo.  Tipo de estudo:  Pré-experimental, pré e pós intervenção, sem grupo controlo.  Local:  ACeS Arrábida - USF Castelo.  População:  Adolescentes com idades compreendidas entre os 10 e os 18 anos inscritas na USF Castelo e utilizadoras de COC.  Métodos:  O estudo decorreu através da análise de dados relativamente à dose de estrogénio do COC utilizado e presença ou ausência de contraindicações absolutas, entre fevereiro de 2019 e fevereiro de 2020, o que permitiu classificar as adolescentes em «bem» ou «mal» medicadas. Procedeu-se a uma primeira avaliação em fevereiro de 2019. De seguida, foi realizada uma intervenção que consistiu em duas fases: a primeira, uma sessão clínica na USF dirigida aos médicos e enfermeiros onde foram divulgados os dados pré-intervenção e feita uma breve apresentação teórica acerca da utilização adequada de COC na adolescência; a segunda fase consistiu no fornecimento de material auxiliar de memória em formato de bolso e afixação de cartazes nos gabinetes onde decorrem as consultas de planeamento familiar. Os outcomes definidos foram: uma taxa de melhoria da prescrição de COC, seis meses depois da intervenção, de 20%; o aumento ou a manutenção da taxa de melhoria inicial, um ano após a intervenção. Foi utilizado o teste exato de Fisher para comparar as taxas de prescrição adequada pré e pós intervenção.  Resultados:  Atingiu-se a melhoria da prescrição de COC nas adolescentes seis meses após a intervenção (21,6%), apesar de não ter sido estatisticamente significativa (p=0,331). Contudo, posteriomente, verificou-se duplicação da taxa de prescrições adequadas prévia, com uma taxa de melhoria de 45,6%, estatisticamente significativa (p&lt;0,001).  Conclusão:  Os profissionais da USF conseguiram implementar as estratégias e melhorar a taxa de prescrições adequadas de COC nas adolescentes. O envolvimento de toda a equipa que realiza aconselhamento contracetivo poderá ter aumentado a eficácia da intervenção. A aplicação das estratégias em apenas uma unidade limita a generalização dos resultados. Contudo, estratégias simples parecem aumentar a taxa de prescrições adequadas de COC nesta faixa etária.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objectives:  To improve and adapt the prescription of combined oral contraceptives (COC) to adolescents in the Family Health Unit (USF) of Castelo.  Type of study:  Pre-experimental, pre, and post-intervention, without a control group.  Place:  ACeS Arrábida - USF Castelo.  Population:  Adolescents aged 10 to 18 years registered at USF Castelo who use COC.  Methods:  The study was carried out by analysing data on the oestrogen dose of the used COC and the presence or absence of absolute contraindications between February 2019 and February 2020, which allowed classifying adolescents as &#8216;well&#8217; or &#8216;badly&#8217; medicated. A first evaluation was carried out in February 2019. This was followed by an intervention consisting of two phases. The first, a clinical session at the USF for doctors and nurses where the pre-intervention data were disclosed and a brief theoretical presentation on the proper use of COC in adolescence was made. The second phase consisted of the supply of pocket-sized memory aids and the display of posters in the offices where family planning consultations take place. The defined outcomes were: a 20% improvement rate of the COC prescription, six months after the intervention; an increase or maintenance of the initial improvement rate, one year after the intervention. Fisher's exact test was used to compare the appropriate pre and post-intervention prescription rates.  Results:  The improvement of COC prescription was achieved in adolescents six months after the intervention (21.6%) although it was not statistically significant (p=0.331). However, thereafter, there was a doubling of the rate of previous appropriate prescriptions, with an improvement rate of 45.6%, statistically significant (p&lt;0.001).  Conclusion:  USF professionals were able to implement strategies and improve the rate of appropriate COC prescriptions in adolescents. The involvement of the entire contraceptive counselling team may have increased the effectiveness of the intervention. Implementing the strategies in only one unit limits the generalization of results. However, simple strategies appear to increase the rate of appropriate COC prescriptions in this age group.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Contracetivos orais combinados]]></kwd>
<kwd lng="pt"><![CDATA[Adolescente]]></kwd>
<kwd lng="pt"><![CDATA[Feminino]]></kwd>
<kwd lng="pt"><![CDATA[Densidade óssea, efeitos de fármacos]]></kwd>
<kwd lng="pt"><![CDATA[Melhoria da qualidade]]></kwd>
<kwd lng="en"><![CDATA[Combined oral contraceptives]]></kwd>
<kwd lng="en"><![CDATA[Adolescent]]></kwd>
<kwd lng="en"><![CDATA[Female]]></kwd>
<kwd lng="en"><![CDATA[Bone density, Drug effects]]></kwd>
<kwd lng="en"><![CDATA[Quality improvement]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Direção-Geral da Saúde</collab>
<source><![CDATA[Saúde infantil e juvenil: programa-tipo de actuação]]></source>
<year>2005</year>
<edition>2</edition>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[DGS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avery]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lazdane]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[What do we know about sexual and reproductive health of adolescents in Europe]]></article-title>
<source><![CDATA[Eur J Contracept Reprod Health Care]]></source>
<year>2010</year>
<volume>15</volume>
<numero>^s2</numero>
<issue>^s2</issue>
<supplement>2</supplement>
<page-range>S54-66</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Neto]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bombas]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Arriaga]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Almeida]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Moleiro]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contraceção na adolescência: recomendações para o aconselhamento contracetivo]]></article-title>
<source><![CDATA[Acta Pediatr Port]]></source>
<year>2014</year>
<volume>45</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>51-63</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>Sociedade Portuguesa de Ginecologia</collab>
<collab>Sociedade Portuguesa da Contracepção</collab>
<collab>Sociedade Portuguesa da Medicina da Reprodução</collab>
<source><![CDATA[Consenso sobre contracepção 2011: reunião de consenso nacional sobre contracepção, Estoril, 15 de janeiro de 2011]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Flegal]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Wei]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ogden]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Freedman]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Curtin]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characterizing extreme values of body mass index-for-age by using the 2000 centers for disease control and prevention growth charts]]></article-title>
<source><![CDATA[Am J Clin Nutr]]></source>
<year>2009</year>
<volume>90</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1314-20</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cibula]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Skrenkova]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hill]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Stepan]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence]]></article-title>
<source><![CDATA[Eur J Endocrinol]]></source>
<year>2012</year>
<volume>166</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1003-11</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gai]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Gai]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of combined oral contraceptive use on bone mineral density in adolescent females]]></article-title>
<source><![CDATA[J Reprod Contracept]]></source>
<year>2012</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>179-85</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Tavares]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Guedes]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efeito da contraceção com etinilestradiol em alta dose na densidade mineral óssea em adolescentes: qual a evidência?]]></article-title>
<source><![CDATA[Rev Port Med Geral Fam]]></source>
<year>2019</year>
<volume>35</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>299-304</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Russell]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wiles]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Improving combined contraceptive pill/oral contraceptives prescribing in general practice]]></article-title>
<source><![CDATA[BMJ Open Qual]]></source>
<year>2017</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marques]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Romeu]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Ruano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Barbosa]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Simões]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recomendações multidisciplinares portuguesas sobre o pedido de DXA e indicação de tratamento de prevenção das fraturas de fragilidade]]></article-title>
<source><![CDATA[Rev Port Med Geral Fam]]></source>
<year>2016</year>
<volume>32</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>425-41</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
